Initial monotherapy and combination therapy and hypertension control the first year
about
Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network.Antihypertensive medication classes used among medicare beneficiaries initiating treatment in 2007-2010.Use of combination antihypertensive therapy initiation in older Americans without prevalent cardiovascular disease.Identifying predictors of blood pressure control in the Lebanese population - a national, multicentric survey -- I-PREDICT.Benefit of initial dual-therapy on stroke prevention in Chinese hypertensive patients: a real world cohort study.A Single-Center, Open-Label, 3-Way Crossover Trial to Determine the Pharmacokinetic and Pharmacodynamic Interaction Between Nebivolol and Valsartan in Healthy Volunteers at Steady State.Fixed-Dose Combinations of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme InhibitorsDiabetes mellitus and vascular diseaseA review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide.Comparative effectiveness of antihypertensive therapeutic classes and treatment strategies in the initiation of therapy in primary care patients: a Distributed Ambulatory Research in Therapeutics Network (DARTNet) studyEfficacy and tolerability of telmisartan plus amlodipine in asian patients not adequately controlled on either monotherapy or on low-dose combination therapy.Blood pressure control with a single-pill combination of indapamide sustained-release and amlodipine in patients with hypertension: the EFFICIENT studyHypertension in black patients: an update.Early combination therapy with telmisartan plus amlodipine for rapid achievement of blood pressure goals.Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker?Thiazide-like/calcium channel blocker agents: a major combination for hypertension management.Understanding the Importance of Race/Ethnicity in the Care of the Hypertensive Patient.The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials.No Time to Waste: in Support of Aggressive and Immediate Management of Hypertension.The power of two: an update on fixed-dose combinations for type 2 diabetes.Low Blood Pressure Is Associated With Greater Risk for Cardiovascular Events in Treated Adults With and Without Apparent Treatment-Resistant Hypertension.How does prescribing for antihypertensive products stack up against guideline recommendations? An Australian population-based study (2006-2014).Switching from a Free Association of Perindopril/Amlodipine to a Fixed-Dose Combination: Increased Antihypertensive Efficacy and Tolerability.Population Pharmacokinetics and Exposure-Response of a Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With Stage 2 Hypertension.Stage 2 hypertension: predictors of failure to achieve blood pressure control and the impact of adding one additional antihypertensive class.Renal denervation with standard radiofrequency ablation catheter is effective in 24-hour ambulatory blood pressure reduction - follow-up at 1/3/6/12 months.Rationale for establishing a mechanism to increase reimbursement to hypertension specialists.Analysis of recent papers in hypertension. Initial combination therapy provides more prompt blood pressure control and reduces cardiovascular events but remains underutilized.Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double-Blind Randomized Controlled Trial.Hypertension in African Americans.Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients.Adhering to the principles of clinical pharmacology - the correct fixed combinations of antihypertensive drugs.Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects.Antihypertensive efficacy of triple combination perindopril/indapamide plus amlodipine in high-risk hypertensives: results of the PIANIST study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients).ARB-based single-pill platform to guide a practical therapeutic approach to hypertensive patients.Full-dose Perindopril/Indapamide in the Treatment of Difficult-to-Control Hypertension: The FORTISSIMO Study.A randomized trial of the efficacy and safety of azilsartan medoxomil combined with chlorthalidone
P2860
Q33789175-F837E145-9006-4E32-98B0-609CBDD785F3Q34084060-9C39097F-C19C-4CDD-A23A-2258AE77D5E9Q34231858-D5A614A7-E446-4FCC-B8C3-DCDE42FF3C2CQ34582437-988ADB29-EAFC-4958-9300-B60CFE3CF86CQ35681055-64C156C9-DB85-492E-AEEA-7BC345B0EA1FQ36098688-C9F45CE1-C896-449E-8ED1-10212C2FC8F7Q36421103-61CF7D7B-CEF8-4D21-9998-40ABB1E88664Q36829126-C0BA991A-4D6D-48F0-A313-A0D2DF0E62BFQ37203105-4C4B0C7F-9AC9-43F1-9C51-8BF5CCB82251Q37569342-B6FA3B53-48EA-41DD-8F00-16C3907459D8Q37639773-7A0667E5-4D98-44AD-AF7F-0BE25A3F0733Q37692238-1A21B502-B208-41C9-9815-A87AFCFB4966Q38113096-1C831036-8759-4FBC-9D4F-61FD8F6980D4Q38129445-99F03C9E-68C8-4574-A0D9-E27217EF6B84Q38144197-F2E65180-03C2-4E4A-9B93-5C10DE8089D8Q38243976-BD13A26D-91C1-4540-B8FB-BB0E678BD4BEQ38371163-394C4097-AA65-4930-8C46-3D4BF2DFB103Q38601013-CF6AA855-3040-419D-92A2-23B1F67AFC79Q38763355-A0C12525-ABB3-4063-83BB-C2F5E3F4A34FQ38920983-F9EE2B9C-AB76-4E2A-BEBE-2DCAFF7F2129Q39262972-928C05EC-8A6C-4BA4-BCBD-87C260E47D2DQ39683030-D4EC490F-FA11-49EC-A4E7-2EF3CD03B4BBQ39823023-95B0F634-F783-4E08-A491-48A850BFB802Q40247257-6FA38B7A-3952-4B23-A018-EBC00D345DB1Q40560812-C2FC3D87-0D40-4A9A-9357-E9B80AED1241Q42422952-2CCA32E4-7AD6-4ED4-84C7-6B54AC1279CBQ44364206-F61A033F-8818-4C5D-847D-1656B113440CQ45005038-5C5A3B95-0201-44B3-9224-35BDA65BEE44Q47124918-319F3258-5FDB-49DA-8D7B-EC43CA5E485DQ47635539-3CC503DE-1493-4E59-A35D-FDF3F4D7F886Q49205064-10B7A647-DCB2-47B0-A0B0-067E02E50E4AQ49384173-7840B1E1-85ED-4EDC-A1A6-A5EAC906D221Q51244807-D210A921-C5CD-43A9-BBCA-905280E0721EQ51750640-D5941C62-8B3F-46CA-B3E1-A02594FB0DC5Q51752848-1690B592-0548-4AB6-A50A-41F43FA0887CQ52802931-7A87D084-56E5-4269-954D-6CE141AAE76FQ58768808-F677B4D6-D5C3-4894-9FB4-9DEF7E861E5D
P2860
Initial monotherapy and combination therapy and hypertension control the first year
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Initial monotherapy and combination therapy and hypertension control the first year
@ast
Initial monotherapy and combination therapy and hypertension control the first year
@en
type
label
Initial monotherapy and combination therapy and hypertension control the first year
@ast
Initial monotherapy and combination therapy and hypertension control the first year
@en
prefLabel
Initial monotherapy and combination therapy and hypertension control the first year
@ast
Initial monotherapy and combination therapy and hypertension control the first year
@en
P2093
P2860
P1433
P1476
Initial monotherapy and combination therapy and hypertension control the first year
@en
P2093
Brent M Egan
C Shaun Wagner
Dipankar Bandyopadhyay
Kristina S Yu-Isenberg
Stephanie R Shaftman
Yumin Zhao
P2860
P304
P356
10.1161/HYPERTENSIONAHA.112.194167
P407
P577
2012-05-07T00:00:00Z